Literature DB >> 20638223

A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion.

Hisato Takagi1, Masafumi Matsui, Takuya Umemoto.   

Abstract

BACKGROUND: Despite the absence of a relationship between cholesterol and abdominal aortic aneurysm (AAA) expansion, there is evidence from a number of studies to suggest that statin therapy may influence AAA expansion, presumably through pleiotropic effects. To confirm whether statin therapy is associated with less AAA expansion, we performed a meta-analysis of clinical controlled studies of statin therapy for prevention of AAA expansion.
METHODS: To identify all clinical studies of statin therapy vs control (no statins) enrolling patients with small (≤ 55 mm) AAA, MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched. For each study, data regarding AAA expansion in both the statin and control groups were used to generate standardized mean differences (SMDs; <0 favoring statin therapy; >0 favoring control) and 95% confidence intervals (CIs). Study-specific estimates were combined using inverse variance-weighted averages of logarithmic SMDs in fixed-effects and random-effects models.
RESULTS: We identified five clinical controlled studies of statin therapy vs control enrolling patients with small AAA, including no randomized and five observational studies. Our meta-analysis included data on 697 patients with small AAA received statin therapy or no statins. Pooled analysis demonstrated that statin therapy was statistically significantly associated with less expansion rates (random-effects SMD, -0.50; 95% CI, -0.75 to -0.25; P = .0001). There was statistically significant trial heterogeneity of results (P = .03). Exclusion of any single trial from the analysis did not substantively alter the overall result of our analysis. There was no evidence of significant publication bias (P = .81).
CONCLUSION: Statin therapy is associated with less expansion rates in patients with small AAA. To confirm our results and more accurately assess the effect of statins on AAA expansion, a large randomized trial is needed.
Copyright © 2010 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20638223     DOI: 10.1016/j.jvs.2010.04.082

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  20 in total

Review 1.  Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.

Authors:  Tom P Theruvath; Jeffrey A Jones; John S Ikonomidis
Journal:  J Card Surg       Date:  2011-09-29       Impact factor: 1.620

2.  Approach to lipid therapy in the patient with atherosclerotic vascular disease.

Authors:  Reena L Pande
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

3.  Suppressive effect of pitavastatin on aortic arch dilatation in acute stanford type B aortic dissection: analysis of STANP trial.

Authors:  Naoki Masaki; Kiichiro Kumagai; Konosuke Sasaki; Satoshi Matsuo; Naotaka Motoyoshi; Osamu Adachi; Masatoshi Akiyama; Shunsuke Kawamoto; Koichi Tabayashi; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-04-06

4.  Statin Use and Aneurysm Risk in Patients With Bicuspid Aortic Valve Disease.

Authors:  Alexander P Taylor; Ajay Yadlapati; Adin-Cristian Andrei; Zhi Li; Colleen Clennon; Patrick M McCarthy; James D Thomas; S Chris Malaisrie; Neil J Stone; Robert O Bonow; Paul W M Fedak; Jyothy J Puthumana
Journal:  Clin Cardiol       Date:  2015-12-22       Impact factor: 2.882

Review 5.  Effect of lipid-modifying therapy on long-term mortality after abdominal aortic aneurysm repair: a systemic review and meta-analysis.

Authors:  Wenwen Zhang; Zhao Liu; Changjian Liu
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

6.  Statins and subarachnoid hemorrhage in Medicare patients with unruptured cerebral aneurysms.

Authors:  Kimon Bekelis; Jeremy Smith; Weiping Zhou; Todd A MacKenzie; David W Roberts; Jonathan Skinner; Nancy E Morden
Journal:  Int J Stroke       Date:  2015-06-29       Impact factor: 5.266

7.  Statin therapy reduces growth of abdominal aortic aneurysms.

Authors:  Wassef Karrowni; Saadeddine Dughman; Georges P Hajj; Francis J Miller
Journal:  J Investig Med       Date:  2011-12       Impact factor: 2.895

Review 8.  Novel mechanisms of abdominal aortic aneurysms.

Authors:  Hong Lu; Debra L Rateri; Dennis Bruemmer; Lisa A Cassis; Alan Daugherty
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

9.  Neurofibromin-deficient myeloid cells are critical mediators of aneurysm formation in vivo.

Authors:  Fang Li; Brandon D Downing; Lucy C Smiley; Julie A Mund; Matthew R Distasi; Waylan K Bessler; Kara N Sarchet; Daniel M Hinds; Lisa M Kamendulis; Cynthia M Hingtgen; Jamie Case; D Wade Clapp; Simon J Conway; Brian K Stansfield; David A Ingram
Journal:  Circulation       Date:  2013-12-26       Impact factor: 29.690

10.  Efficacy and mechanism of angiotensin II receptor blocker treatment in experimental abdominal aortic aneurysms.

Authors:  Yasunori Iida; Baohui Xu; Geoffrey M Schultz; Vinca Chow; Julie J White; Shola Sulaimon; Ayala Hezi-Yamit; Susan Rea Peterson; Ronald L Dalman
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.